Orchestra BioMed Holdings, Inc.
OBIO • NASDAQ
Orchestra BioMed Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Hochman, with a market cap of $247.5M.
Market Cap$247.5M
Employees56.0
CEODavid Hochman
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Orchestra BioMed Holdings, Inc. FAQ
Common questions about Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026 before market open. Analysts estimate revenue of $923.6K.
Orchestra BioMed Holdings, Inc. has approximately 56 employees.